A Study of PD5K3 in Healthy Adult Volunteers

Clinical trial NCT06527781 · COMPLETED

Trial details

NCT number: NCT06527781
Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma

Start date: 2023-11-27
Primary completion: 2024-05-20
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.